Skip to content
2000
Volume 20, Issue 28
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

DNAzymes are DNA-based catalytic molecules that have potential use in a range of disorders where the targeted gene plays an important role in disease pathogenesis. DNAzymes are at a comparatively early developmental stage as alternatives to conventional therapies. The biological action of DNAzymes on target mRNA requires efficient delivery into target cells and this hurdle has hampered their broader use, particularly in systemic settings. DNAzymes have been delivered in naked form without a carrier or combined with agents such as polymers and liposomes. This article reviews these and other delivery approaches and offers perspectives on future methodologies for improved DNAzyme delivery and utility as novel drugs.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/09298673113209990033
2013-09-01
2025-04-10
Loading full text...

Full text loading...

/content/journals/cmc/10.2174/09298673113209990033
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test